Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria

Vaccine

Volumn 25, Issue 48, 2007, Pages 8198-8202

  Bejon, Philip ^a   Mwangi, Tabitha ^a,b   Lowe, Brett ^a   Peshu, Norbert ^a   Hill, Adrian V S ^b,c   Marsh, Kevin ^a,d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Definition; Febrile malaria; Malaria attributable fraction; Plasmodium falciparum; Specificity

Indexed keywords

ANTIMALARIAL AGENT; DIHYDROARTEMISININ; MALARIA VACCINE;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG CLEARANCE; FEVER; FOLLOW UP; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA; MONOTHERAPY; OUTCOME ASSESSMENT; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOM; VACCINATION;

ANTIMALARIALS; BODY TEMPERATURE; CHILD; CLINICAL TRIALS AS TOPIC; FEVER; HUMANS; LOGISTIC MODELS; MALARIA; MALARIA, FALCIPARUM; PARASITEMIA; REGRESSION ANALYSIS;

EID: 35748961698     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.057     Document Type: Article

References (17)

1. Alonso P.L., Sacarlal J., Aponte J.J., Leach A., Macete E., Milman J., et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364 9443 (2004) 1411-1420
2. Alonso P.L., Smith T., Schellenberg J.R., Masanja H., Mwankusye S., Urassa H., et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344 8931 (1994) 1175-1181
3. Bejon P., Mwacharo J., Kai O., Mwangi T., Milligan P., Todryk S., et al. A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials 1 6 (2006) e29
4. Genton B., Betuela I., Felger I., Al-Yaman F., Anders R.F., Saul A., et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 185 6 (2002) 820-827
5. Armstrong Schellenberg J.R., Smith T., Alonso P.L., and Hayes R.J. What is clinical Malaria? Finding case definitions for field research in highly endemic areas. Parasitol Today 10 11 (1994) 439-441
6. Blackwelder W.C., Storsaeter J., Olin P., and Hallander H.O. Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions. Am J Dis Child 145 11 (1991) 1285-1289
7. Lachenbruch P.A. Sensitivity, specificity, and vaccine efficacy. Control Clin Trials 19 6 (1998) 569-574
8. Quade D., Lachenbruch P.A., Whaley F.S., McClish D.K., and Haley R.W. Effects of misclassifications on statistical inferences in epidemiology. Am J Epidemiol 111 5 (1980) 503-515
9. Schellenberg D., Cisse B., and Menendez C. The IPTi Consortium: research for policy and action. Trends Parasitol 22 7 (2006) 296-300
10. Bojang K.A., Milligan P.J., Pinder M., Vigneron L., Alloueche A., Kester K.E., et al. Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358 9297 (2001) 1927-1934
11. Moorthy V.S., Imoukhuede E.B., Milligan P., Bojang K., Keating S., Kaye P., et al. A randomised, double-blind controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. Plos Med 1 2 (2004) e33
12. Smith T., Schellenberg J.A., and Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 13 22 (1994) 2345-2358
13. Mwangi T.W., Ross A., Snow R.W., and Marsh K. Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis 191 11 (2005) 1932-1939
14. Rogers W.O., Atuguba F., Oduro A.R., Hodgson A., and Koram K.A. Clinical case definitions and malaria vaccine efficacy. J Infect Dis 193 3 (2006) 467-473
15. Rougemont A., Breslow N., Brenner E., Moret A.L., Dumbo O., Dolo A., et al. Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa. Lancet 338 8778 (1991) 1292-1295
16. Graves P., and Gelband H. Vaccines for preventing malaria (blood-stage). Cochrane Database Syst Rev 4 (2006) CD006199
17. Alonso P.L., Sacarlal J., Aponte J.J., Leach A., Macete E., Aide P., et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366 9502 (2005) 2012-2018